Introduction to MK-4827 (tosylate) (CAS 1038915-73-9)
MK-4827 (tosylate) with the CAS number 1038915-73-9 is a compound that has gained significant attention in the scientific and pharmaceutical communities. This article aims to provide a comprehensive overview of MK-4827 (tosylate), including its properties, uses, applications in various fields, and preparation methods.
Properties of MK-4827 (tosylate)
MK-4827 (tosylate) is a chemical compound with specific physical and chemical properties. Physically, it has a certain appearance, which might be in the form of a powder or crystals depending on the purification and synthesis conditions. Its solubility is an important property. It may have solubility in certain organic solvents such as dimethyl sulfoxide (DMSO), ethanol, or methanol. The solubility in water is also a factor that affects its application in biological and pharmaceutical systems. Chemically, it has a defined molecular structure. The tosylic acid salt form influences its stability, reactivity, and interaction with other molecules. The compound may have a characteristic melting point, boiling point, and density, which are crucial for its handling and processing in laboratories and industrial settings.
Uses of MK-4827 (tosylate)
In the pharmaceutical field, MK-4827 (tosylate) has shown potential as a therapeutic agent. It may act on specific biological targets within the human body. For example, it could target certain enzymes or receptors involved in disease pathways. By binding to these targets, it may modulate their activity, leading to a therapeutic effect. In cancer research, it might be investigated for its ability to inhibit the growth and proliferation of cancer cells. It could interfere with the signaling pathways that are crucial for cancer cell survival and metastasis. In addition, it may have applications in the treatment of other diseases such as neurodegenerative disorders. It could potentially protect neurons from damage or promote their regeneration.
In the research and development of new drugs, MK-4827 (tosylate) serves as a valuable tool compound. Scientists can use it to study the function of specific biological molecules and pathways. By observing the effects of MK-4827 (tosylate) on cells or animal models, they can gain insights into the underlying mechanisms of diseases and develop new therapeutic strategies. It can also be used in high – throughput screening assays to identify other potential drug candidates with similar or improved activities.
Applications in Various Fields
Biomedical Research: In cell culture experiments, MK-4827 (tosylate) can be added to the culture medium to study its effects on cell behavior. For example, it can be used to investigate the impact on cell cycle progression, apoptosis, and gene expression. In animal models, it can be administered to study its in – vivo efficacy and toxicity. This helps in understanding the pharmacokinetics and pharmacodynamics of the compound, which are essential for the development of safe and effective drugs.
Pharmaceutical Industry: As a potential drug candidate, MK-4827 (tosylate) may go through pre – clinical and clinical trials. In pre – clinical trials, it is tested on animals to evaluate its safety and efficacy. If the results are promising, it will progress to clinical trials, where it is tested on human subjects. The pharmaceutical industry also uses MK-4827 (tosylate) as a reference compound for the development of new drugs with similar or improved properties. It can be used as a starting point for chemical modifications to optimize its activity, selectivity, and pharmacokinetic profile.
Chemical Research: Chemists can use MK-4827 (tosylate) to study chemical reactions and synthesis methods. It can be used as a substrate or reagent in organic synthesis to develop new chemical compounds. The tosylic acid salt form can also influence the reaction conditions and selectivity, providing opportunities for the discovery of new synthetic routes.
Preparation Methods of MK-4827 (tosylate)
The preparation of MK-4827 (tosylate) typically involves a multi – step synthesis process. The first step usually starts with the selection of appropriate starting materials. These starting materials should have the necessary functional groups and molecular skeletons to build the structure of MK-4827. The synthesis may involve several chemical reactions such as condensation reactions, substitution reactions, and oxidation – reduction reactions.
For example, in the initial steps, two or more small molecules may be reacted together through a condensation reaction to form a larger intermediate compound. This intermediate is then further modified through substitution reactions to introduce specific functional groups at the desired positions. Oxidation – reduction reactions may be used to adjust the oxidation state of certain atoms in the molecule. After the synthesis of the free base of MK-4827, the tosylic acid salt is formed by reacting the free base with tosylic acid in an appropriate solvent. The reaction conditions such as temperature, reaction time, and the ratio of reactants need to be carefully controlled to ensure high yield and purity of the final product.
Purification is an important step in the preparation process. After the synthesis of MK-4827 (tosylate), it may contain impurities such as unreacted starting materials, by – products, and solvents. Purification methods such as chromatography, recrystallization, and distillation can be used to remove these impurities and obtain a pure product. Chromatography, such as column chromatography or high – performance liquid chromatography (HPLC), can separate the compound from other substances based on their different physical and chemical properties. Recrystallization involves dissolving the compound in a suitable solvent and then allowing it to crystallize out, which can effectively remove impurities that are not incorporated into the crystal lattice. Distillation can be used to separate the compound from volatile solvents or low – boiling impurities.
References
- [1] [Title of relevant research paper 1]. Link to paper 1
- [2] [Title of relevant research paper 2]. Link to paper 2